Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

EU flag

New cancer meds and drug extensions top CHMP recommendations

Drugs for rare disease, oncology and diabetes top regulator’s endorsements

- PMLiVE

Gilead’s Harvoni gains NICE yes – but won’t face funding delay

Unlike the company's Sovaldi, which won’t be paid for until the summer

- PMLiVE

J&J sells Cordis unit to Cardinal Health for $1.94bn

Marks J&J’s exit from the cardiovascular stent market

- PMLiVE

Publicis Healthcare names North America group president

Alexandra von Plato to take up the role

- PMLiVE

Complaints about UK medical advertising drop

And this year the MHRA will be vetting adverts to promote a ‘right first time’ approach

- PMLiVE

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year

Ex Sanofi boss joins Boston start-up

Chris Viehbacher joins other industry veterans as the newest board member of PureTech

- PMLiVE

Cidara Therapeutics makes senior appointments

Paul Daruwala and James Balkovec join the biotech

- PMLiVE

Peter Nightingale appointed as chair of new MHRA committee

Was formerly president of the Intensive Care Society

- PMLiVE

Novartis and GSK complete oncology and vaccines swap

Follows Swiss company's decision to divest its BRAF and MEK inhibitors to Array BioPharma

- PMLiVE

Amgen’s Kyprolis tops Velcade in myeloma trial

Amgen hoping to topple Takeda’s $2bn a year drug

Does ‘trust leadership’ feature in your strategy?

Pharma companies wanting to be more patient-focused will need to develop their people skills

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links